全球照护现场/快速诊断市场

Point-of-Care/Rapid Diagnostics

出版日期: 2024年08月28日 | 出版商:

Global Industry Analysts, Inc. | 英文 376 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球照护现场/快速诊断市场将达到 464 亿美元

全球照护现场/快速诊断市场预计 2023 年为 277 亿美元，预计到 2030 年将达到 464 亿美元，在 2023-2030 年分析期间复合年增长率为 7.7%。其他 POC 产品是本报告分析的细分市场之一，预计复合年增长率为 6.1%，到分析期结束时将达到 33 亿美元。分析期间，滥用药物测试产品领域的复合年增长率预计为 6.4%。

美国市场预计75亿美元，中国预计复合年增长率11.2%

到 2023 年，美国照护现场/快速诊断市场预计将达到 75 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到100亿美元，2023-2030年分析期间复合年增长率为11.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 5.3% 和 5.9%。在欧洲，德国的复合年增长率预计为 5.9%。

全球照护现场/快速诊断市场—主要趋势和驱动因素总结

照护现场/快速诊断对医疗保健革命的影响

照护现场(POC) 或快速诊断是在患者护理点或附近进行的医学测试，无需大量测试基础设施即可提供即时结果。这些诊断涵盖广泛的应用，包括感染疾病检测、血糖监测、心臟标记和怀孕检测。 POC 诊断通常涉及使用携带式设备和检测套组的简单程序，并且需要最少的操作训练。例如，常用于家庭怀孕测试和 COVID-19 抗原测试的侧向层析检测可以透过检测检体中是否存在特定生物标记来提供快速的视觉结果。其他 POC 技术，例如可携式血液分析仪和手持式分子检测设备，使用微流体和核酸扩增等先进技术来提供准确、及时的结果。 POC 诊断的核心优势在于，它为医疗保健专业人员提供即时可操作的信息，促进更快的临床决策并改善患者的治疗结果。

如何在各种医疗环境中使用照护现场/快速诊断？

POC 测试在各种医疗环境中至关重要，可以提高医疗保健服务的效率和效果。在急诊科，POC 测试用于快速诊断心肌梗塞等疾病，以便即时采取干预措施，这对挽救生命至关重要。初级保健和门诊诊所可以现场测试和诊断链球菌性感染疾病、流感和尿道感染等常见疾病，从而减少重复就诊的需要并简化患者护理。偏远和农村医疗机构往往缺乏先进的检测能力，严重依赖 POC 诊断来填补医疗保健服务缺口并提供基本医疗服务。此外，POC诊断在慢性病管理中发挥重要作用，使患者能够家用监测糖尿病和凝血等状况，从而更好地管理自己的健康。 POC 诊断功能多样且快速，使其成为各种医疗保健环境中的重要工具。

POC/快速诊断技术的发展趋势是什么？

由于技术创新和对高效医疗保健解决方案不断增长的需求，照护现场正在迅速发展。一个关键趋势是数位健康技术的集成，配备连接功能的 POC 设备可将测试结果直接上传到电子健康记录(EHR) 和行动医疗应用程序，从而使即时资料共用和远端患者监控变得更加容易。另一个趋势是多重检测平台的开发，它允许从单一样本同时检测多个生物标记物，对于诊断合併感染疾病和全面的健康筛检特别有用。微流体和实验室晶片技术的进步促进了更紧凑、更便携的 POC 设备的开发，这些设备具有更高的灵敏度和特异性。此外，人工智慧 (AI) 和机器学习演算法的使用正在提高 POC 诊断的准确性和预测能力，并根据患者资料提供个人化见解。这些趋势正在改变快速诊断的格局，使其更容易获得、更可靠，并融入更广泛的医疗保健系统。

照护现场/快速诊断市场成长的因素有哪些？

照护现场/快速诊断市场的成长是由多种因素推动的，反映出对及时、准确的诊断解决方案的需求不断增长。糖尿病和 COVID-19 等慢性病和感染疾病的日益普及是一个关键驱动因素，因为 POC 诊断能够及早发现和管理这些疾病。技术进步提高了 POC 设备的功能和易用性，支持其在各种医疗保健环境中的采用。此外，对个人化医疗的日益重视和医疗保健的日益分散化意味着 POC 诊断支持个人化治疗计划并促进传统临床环境之外的治疗，正在推动市场成长。此外，医疗基础设施投资的增加和远端医疗服务的扩展也推动了对快速诊断工具的需求。旨在改善偏远地区疾病监测和医疗保健服务的公共卫生措施进一步推动了市场扩张。这些因素结合起来，确保了照护现场/快速诊断市场的强劲成长，凸显了照护现场/快速诊断在现代医疗保健服务和疾病管理中的关键作用。

受访企业范例（共13例）

Abbott Laboratories
AccuBioTech Co., Ltd.
Becton, Dickinson and Company
Chembio Diagnostic Systems, Inc.
Danaher Corporation
EKF Diagnostics Holdings PLC
Instrumentation Laboratory
Johnson & Johnson
Nova Biomedical Corporation
PTS Diagnostics
Quidel Corporation
Roche Diagnostics（Schweiz）AG
Sekisui Diagnostics LLC
Siemens AG
Trinity Biotech PLC

The global market for Point-of-Care/Rapid Diagnostics estimated at US$27.7 Billion in the year 2023, is expected to reach US$46.4 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Other POC Products, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Drugs-of-Abuse Testing Products segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.5 Billion While China is Forecast to Grow at 11.2% CAGR

The Point-of-Care/Rapid Diagnostics market in the U.S. is estimated at US$7.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$10.0 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.3% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Global Point-of-Care/Rapid Diagnostics Market - Key Trends and Drivers Summarized

Revolutionizing Healthcare: The Impact of Point-of-Care/Rapid Diagnostics

Point-of-care (POC) or rapid diagnostics are medical tests performed at or near the site of patient care, providing immediate results without the need for extensive laboratory infrastructure. These diagnostics cover a wide range of applications, including infectious disease detection, blood glucose monitoring, cardiac markers, and pregnancy testing. POC diagnostics typically involve simple procedures using portable devices or test kits that require minimal training to operate. For instance, lateral flow assays, commonly used in home pregnancy tests and COVID-19 antigen tests, allow for rapid visual results by detecting the presence of specific biomarkers in a sample. Other POC technologies, such as portable blood analyzers and handheld molecular testing devices, use advanced techniques like microfluidics and nucleic acid amplification to deliver precise and timely results. The core advantage of POC diagnostics is their ability to provide healthcare professionals with immediate, actionable information, facilitating faster clinical decisions and improving patient outcomes.

How Are Point-of-Care/Rapid Diagnostics Utilized in Various Medical Settings?

Point-of-care diagnostics are integral to various medical settings, enhancing the efficiency and effectiveness of healthcare delivery. In emergency departments, POC tests are used to quickly diagnose conditions like myocardial infarction, enabling immediate intervention that can be critical in saving lives. In primary care and outpatient clinics, these diagnostics allow for on-the-spot testing and diagnosis of common conditions such as strep throat, influenza, and urinary tract infections, reducing the need for follow-up visits and streamlining patient care. Remote and rural healthcare facilities, often lacking advanced laboratory capabilities, rely heavily on POC diagnostics to provide essential medical services, bridging the gap in healthcare access. Additionally, POC diagnostics play a crucial role in chronic disease management, allowing patients to monitor conditions such as diabetes and coagulation disorders at home, thereby maintaining better control over their health. The versatility and rapid turnaround of POC diagnostics make them indispensable tools across diverse healthcare environments.

What Are the Current Trends in Point-of-Care/Rapid Diagnostic Technology?

The field of point-of-care diagnostics is experiencing rapid advancements driven by technological innovations and the increasing demand for efficient healthcare solutions. One significant trend is the integration of digital health technologies, where POC devices are equipped with connectivity features to upload test results directly to electronic health records (EHRs) and mobile health applications, facilitating real-time data sharing and remote patient monitoring. The development of multiplex testing platforms is another trend, enabling the simultaneous detection of multiple biomarkers from a single sample, which is particularly useful for diagnosing co-infections or comprehensive health screenings. Advances in microfluidics and lab-on-a-chip technologies are leading to the creation of more compact and portable POC devices with enhanced sensitivity and specificity. Additionally, the use of artificial intelligence (AI) and machine learning algorithms is improving the accuracy and predictive capabilities of POC diagnostics, offering personalized insights based on patient data. These trends are revolutionizing the landscape of rapid diagnostics, making them more accessible, reliable, and integrated into the broader healthcare system.

What Factors Are Driving the Growth in the Point-of-Care/Rapid Diagnostics Market?

The growth in the point-of-care/rapid diagnostics market is driven by several factors, reflecting the increasing need for timely and accurate diagnostic solutions. The rising prevalence of chronic diseases and infectious diseases, such as diabetes and COVID-19, is a significant driver, as POC diagnostics enable early detection and management of these conditions. Technological advancements are enhancing the functionality and user-friendliness of POC devices, encouraging their adoption across various healthcare settings. The growing emphasis on personalized medicine and the shift towards decentralized healthcare are also propelling market growth, as POC diagnostics support individualized treatment plans and facilitate care outside traditional clinical environments. Additionally, increasing investments in healthcare infrastructure and the expansion of telemedicine services are boosting demand for rapid diagnostic tools. Public health initiatives aimed at improving disease surveillance and healthcare accessibility in remote areas further support market expansion. These factors collectively ensure robust growth in the point-of-care/rapid diagnostics market, underscoring their critical role in modern healthcare delivery and disease management.

Select Competitors (Total 13 Featured) -

Abbott Laboratories
AccuBioTech Co., Ltd.
Becton, Dickinson and Company
Chembio Diagnostic Systems, Inc.
Danaher Corporation
EKF Diagnostics Holdings PLC
Instrumentation Laboratory
Johnson & Johnson
Nova Biomedical Corporation
PTS Diagnostics
Quidel Corporation
Roche Diagnostics (Schweiz) AG
Sekisui Diagnostics LLC
Siemens AG
Trinity Biotech PLC

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Point-Of-Care/Rapid Diagnostics: Overview & Outlook
- Point-of-Care/Rapid Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Emphasis on Decentralized Testing & Laboratory Strengthening Programs Augurs Well
- Emergency Departments Rely on Rapid POC Diagnostics
- Rapid POC Diagnostics Streamline Urgent Cardiac Care Settings
- Rapid POC Diagnostics Gain Traction in Diagnosis of STD
- Rapid POC Diagnostics for Tuberculosis Diagnosis
- Quality Assurances Accelerate Adoption
- Issues & Challenges
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Point-of-Care/Rapid Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Glucose Monitoring Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Glucose Monitoring Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Glucose Monitoring Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Cardiometabolic Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Cardiometabolic Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Cardiometabolic Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Infectious Disease Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Infectious Disease Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Infectious Disease Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Coagulation Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 14: World Historic Review for Coagulation Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 15: World 16-Year Perspective for Coagulation Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 16: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 17: World Historic Review for Pregnancy & Fertility Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 18: World 16-Year Perspective for Pregnancy & Fertility Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 19: World Recent Past, Current & Future Analysis for Tumor/Cancer Marker Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 20: World Historic Review for Tumor/Cancer Marker Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 21: World 16-Year Perspective for Tumor/Cancer Marker Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 22: World Recent Past, Current & Future Analysis for Urinalysis Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 23: World Historic Review for Urinalysis Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 24: World 16-Year Perspective for Urinalysis Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 25: World Recent Past, Current & Future Analysis for Cholesterol Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 26: World Historic Review for Cholesterol Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 27: World 16-Year Perspective for Cholesterol Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 28: World Recent Past, Current & Future Analysis for Hematology Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 29: World Historic Review for Hematology Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 30: World 16-Year Perspective for Hematology Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 31: World Recent Past, Current & Future Analysis for Drugs-of-Abuse Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 32: World Historic Review for Drugs-of-Abuse Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 33: World 16-Year Perspective for Drugs-of-Abuse Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 34: World Recent Past, Current & Future Analysis for Fecal Occult Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 35: World Historic Review for Fecal Occult Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 36: World 16-Year Perspective for Fecal Occult Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 37: World Recent Past, Current & Future Analysis for Other POC Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 38: World Historic Review for Other POC Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 39: World 16-Year Perspective for Other POC Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 40: World Recent Past, Current & Future Analysis for OTC-based Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 41: World Historic Review for OTC-based Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 42: World 16-Year Perspective for OTC-based Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 43: World Recent Past, Current & Future Analysis for Prescription-based Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 44: World Historic Review for Prescription-based Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 45: World 16-Year Perspective for Prescription-based Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 46: World Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 47: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 48: World 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 49: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 50: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 51: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 52: World Recent Past, Current & Future Analysis for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 53: World Historic Review for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 54: World 16-Year Perspective for Microfluidics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 55: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 56: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 57: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 58: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 59: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 60: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 61: World Point-of-Care/Rapid Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 62: USA Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: USA Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: USA 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 65: USA Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 66: USA Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: USA 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 68: USA Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: USA Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: USA 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
CANADA
- TABLE 71: Canada Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 72: Canada Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: Canada 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 74: Canada Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: Canada Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: Canada 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 77: Canada Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: Canada Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: Canada 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
JAPAN
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 80: Japan Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: Japan Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: Japan 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 83: Japan Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: Japan Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: Japan 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 86: Japan Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: Japan Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: Japan 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
CHINA
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 89: China Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 90: China Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: China 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 92: China Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 93: China Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 94: China 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 95: China Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 96: China Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 97: China 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
EUROPE
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 98: Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 99: Europe Historic Review for Point-of-Care/Rapid Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 100: Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 101: Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 102: Europe Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 103: Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 104: Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 105: Europe Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 106: Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 107: Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 108: Europe Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 109: Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
FRANCE
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 110: France Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 111: France Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 112: France 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 113: France Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 114: France Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 115: France 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 116: France Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 117: France Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 118: France 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
GERMANY
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 119: Germany Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 120: Germany Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 121: Germany 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 122: Germany Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 123: Germany Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 124: Germany 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 125: Germany Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 126: Germany Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 127: Germany 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
ITALY
- TABLE 128: Italy Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 129: Italy Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 130: Italy 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 131: Italy Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 132: Italy Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 133: Italy 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 134: Italy Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 135: Italy Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 136: Italy 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 137: UK Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 138: UK Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 139: UK 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 140: UK Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 141: UK Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 142: UK 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 143: UK Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 144: UK Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 145: UK 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
SPAIN
- TABLE 146: Spain Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 147: Spain Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 148: Spain 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 149: Spain Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 150: Spain Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 151: Spain 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 152: Spain Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 153: Spain Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 154: Spain 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
RUSSIA
- TABLE 155: Russia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 156: Russia Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 157: Russia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 158: Russia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 159: Russia Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 160: Russia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 161: Russia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 162: Russia Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 163: Russia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 165: Rest of Europe Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 166: Rest of Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 168: Rest of Europe Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 169: Rest of Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 171: Rest of Europe Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 172: Rest of Europe 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 174: Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 175: Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 177: Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 178: Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 180: Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 181: Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 183: Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 184: Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
AUSTRALIA
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- TABLE 185: Australia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 186: Australia Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 187: Australia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 188: Australia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 189: Australia Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 190: Australia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 191: Australia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 192: Australia Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 193: Australia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
INDIA
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- TABLE 194: India Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 195: India Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 196: India 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 197: India Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 198: India Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 199: India 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 200: India Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 201: India Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 202: India 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
SOUTH KOREA
- TABLE 203: South Korea Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 204: South Korea Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 205: South Korea 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 206: South Korea Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 207: South Korea Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 208: South Korea 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 209: South Korea Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 210: South Korea Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 211: South Korea 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
- TABLE 212: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 213: Rest of Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 214: Rest of Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 215: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 216: Rest of Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 217: Rest of Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 218: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 219: Rest of Asia-Pacific Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 220: Rest of Asia-Pacific 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
LATIN AMERICA
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- TABLE 221: Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 222: Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 223: Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- TABLE 224: Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 225: Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 226: Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 227: Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 228: Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 229: Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 230: Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 231: Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 232: Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
ARGENTINA
- TABLE 233: Argentina Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 234: Argentina Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 235: Argentina 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 236: Argentina Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 237: Argentina Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 238: Argentina 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 239: Argentina Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 240: Argentina Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 241: Argentina 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
BRAZIL
- TABLE 242: Brazil Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 243: Brazil Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 244: Brazil 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 245: Brazil Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 246: Brazil Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 247: Brazil 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 248: Brazil Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 249: Brazil Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 250: Brazil 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
MEXICO
- TABLE 251: Mexico Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 252: Mexico Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 253: Mexico 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 254: Mexico Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 255: Mexico Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 256: Mexico 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 257: Mexico Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 258: Mexico Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 259: Mexico 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
- TABLE 260: Rest of Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 261: Rest of Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 262: Rest of Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 263: Rest of Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 264: Rest of Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 265: Rest of Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 266: Rest of Latin America Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 267: Rest of Latin America Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 268: Rest of Latin America 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
MIDDLE EAST
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- TABLE 269: Middle East Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 270: Middle East Historic Review for Point-of-Care/Rapid Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 271: Middle East 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- TABLE 272: Middle East Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 273: Middle East Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 274: Middle East 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 275: Middle East Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 276: Middle East Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 277: Middle East 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 278: Middle East Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 279: Middle East Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 280: Middle East 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
IRAN
- TABLE 281: Iran Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 282: Iran Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 283: Iran 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 284: Iran Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 285: Iran Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 286: Iran 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 287: Iran Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 288: Iran Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 289: Iran 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
ISRAEL
- TABLE 290: Israel Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 291: Israel Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 292: Israel 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 293: Israel Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 294: Israel Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 295: Israel 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 296: Israel Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 297: Israel Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 298: Israel 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
SAUDI ARABIA
- TABLE 299: Saudi Arabia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 300: Saudi Arabia Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 301: Saudi Arabia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 302: Saudi Arabia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 303: Saudi Arabia Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 304: Saudi Arabia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 305: Saudi Arabia Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 306: Saudi Arabia Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 307: Saudi Arabia 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
- TABLE 308: UAE Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 309: UAE Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 310: UAE 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 311: UAE Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 312: UAE Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 313: UAE 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 314: UAE Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 315: UAE Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 316: UAE 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
- TABLE 317: Rest of Middle East Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 318: Rest of Middle East Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 319: Rest of Middle East 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 320: Rest of Middle East Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 321: Rest of Middle East Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 322: Rest of Middle East 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 323: Rest of Middle East Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 324: Rest of Middle East Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 325: Rest of Middle East 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030
AFRICA
- Point-of-Care/Rapid Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- TABLE 326: Africa Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 327: Africa Historic Review for Point-of-Care/Rapid Diagnostics by Product - Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 328: Africa 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Product - Percentage Breakdown of Value Sales for Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products and Other POC Products for the Years 2014, 2024 & 2030
- TABLE 329: Africa Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 330: Africa Historic Review for Point-of-Care/Rapid Diagnostics by Mode - OTC-based Testing and Prescription-based Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 331: Africa 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Mode - Percentage Breakdown of Value Sales for OTC-based Testing and Prescription-based Testing for the Years 2014, 2024 & 2030
- TABLE 332: Africa Recent Past, Current & Future Analysis for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 333: Africa Historic Review for Point-of-Care/Rapid Diagnostics by Platform - Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 334: Africa 16-Year Perspective for Point-of-Care/Rapid Diagnostics by Platform - Percentage Breakdown of Value Sales for Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays for the Years 2014, 2024 & 2030